Top

Published in:

01-01-2010 | Brief Report

Segment-2 sequence analysis and cross-neutralization studies on some Indian bluetongue viruses suggest isolates are VP2-variants of serotype 23

Authors: Prabhakar A. Tembhurne, Bimalendu Mondal, Kunj B. Pathak, Sanchay K. Biswas, Aniket Sanyal, Mahendra P. Yadav, Santanu K. Bandyopadhyay, Raj K. Singh

Published in: Archives of Virology | Issue 1/2010

Abstract

Sequence analysis of segment 2 (seg-2) of three Indian bluetongue virus (BTV) isolates, Dehradun, Rahuri and Bangalore revealed 99% nucleotide identity amongst them and 96% with the reference BTV 23. Phylogenetic analysis grouped the isolates in ‘nucleotype D’. The deduced amino acid (aa) sequence of the Bangalore isolate showed a high variability in a few places compared to other isolates. B-cell epitope analyses predicted an epitope that is present exclusively in the Bangalore isolate. Two-way cross serum neutralization confirmed that Bangalore isolate is antigenically different from the other two isolates. The results of this study suggest that these three isolates are VP2 variants of BTV 23. This signifies that non-cross-neutralizing variants of the same BTV serotype should be included in vaccine preparation.

Bonneau KR, Zhang N, Zhu J, Zhang F, Li Z, Zhang K, Xiao L, Xiang W, MacLachlan NJ (1999) Sequence comparison of the L2 and S10 genes of bluetongue viruses from the United States and the People’s Republic of China. Virus Res 61:153–160CrossRefPubMed

Clarke IN, McCrae MA (1981) A rapid and sensitive method for analyzing the genome profiles of field isolates of rotavirus. J Virol Methods 2:203–209CrossRefPubMed

Cowley JA, Gorman BM (1989) Cross-neutralization of genetic reassortants of bluetongue virus serotypes 20 and 21. Vet Microbiol 19:37–51CrossRefPubMed

DeMatto CA, DeMattos CCP, Osburn IB, MacLachlan NJ (1994) Heterogeneity of the L2 gene of field isolates of bluetongue virus serotype-17 from the San-Joaquin valley of California. Virus Res 31:67–87CrossRef

DeMattos CCP, DeMattos CA, Osburn IB, MacLachlan NJ (1994) Evolution of the L2 gene of strains of bluetongue virus serotype-10 isolated in California. Virology 201:173–177CrossRef

DeMaula CD, Heinder HW, Rossitto PV, Peirce CM, MacLachlan NJ (1993) Neutralization determinants of United States bluetongue virus serotype 10. Virology 195:292–296CrossRefPubMed

Enserink M (2006) Emerging infectious diseases. During a hot summer, bluetongue virus invades northern Europe. Science 313:1218–1219CrossRefPubMed

Erasmus BJ (1990) Bluetongue virus. In: Dinter Z, Morein B (eds) Virus infection of ruminants, vol 3. Elsevier, Amsterdam, New York, pp 227–237

Felsenstein J (1985) Confidence limits on phylogenesis: an approach using the bootstrap. Evolution 39:783–791CrossRef

10.

Gould AR, Pritchard LI (1990) Relationships amongst bluetongue viruses revealed by comparisons of capsid and outer coat protein nucleotide sequences. Virus Res 17:31–52CrossRefPubMed

11.

Hamblin C (2004) Bluetongue virus antigen and antibody detection, and the application of laboratory diagnostic techniques. Vet Ital 40:538–545

12.

Jain NC, Sharma R, Prasad G (1986) Isolation of bluetongue virus from sheep in India. Vet Rec 119:17–18PubMed

13.

Kimura M (1980) A simple method for estimating evolutionary rates of base substitutions through comparative studies of nucleotide sequences. J Mol Evol 16:783–791CrossRef

14.

Knudson DL, Butterfield WK, Shope RE, Walton TE, Campbell CH (1982) Electrophoresis comparisons of the genomes of North American bluetongue viruses, one Australian bluetongue virus and three other related orbivirus. Vet Microbiol 7:285–293CrossRefPubMed

15.

Koekemoer JJO, Paweska JT, Pretorus PJ, van Dijk AA (2003) VP2 gene phylogenetic characterization of field isolates of African horse sickness virus serotype 7 circulating in South Africa during the time of the 1999 African horsesickness outbreak in the Western cape. Virus Res 93:159–167CrossRefPubMed

16.

Maan S, Maan NS, Samuel AR, Rao S, Attoui H, Mertens PPC (2007) Analysis and phylogenetic comparisons of full-length VP2 genes of the 24 bluetongue virus serotypes. J Gen Virol 88:621–630CrossRefPubMed

17.

McColl KA, Gould AR (1991) Detection and characterization of bluetongue virus using the polymerase chain reaction. Virus Res 21:19–34CrossRefPubMed

18.

Mehrotra ML, Shukla DC, Kataria JM (1989) Isolation and identification of viral agent resembling bluetongue virus in an outbreak in sheep. Indian J Anim Sci 59:1072–1074

19.

Mehrotra ML, Shukla DC, Singh KP, Khanna PN, Saikumar G (1995) Isolation of bluetongue virus from an outbreak of Morbillivirus infection in sheep and goat. J Comp Microbiol Immunol Infect Dis 16:135–136

20.

Mertens PPC, Maan NS, Prasad G, Samuel AR, Shaw AE, Potgieter AC, Anthony SJ, Maan S (2007) The design of primers and use of RT-PCR assays for typing European BTV isolates: differentiation of field and vaccine strains. J Gen Virol 88:2811–2823CrossRefPubMed

21.

Mertens PPC, Maan S, Samuel A, Attoui H (2004) Oribivirus, Reoviridae. In: Fauquet CM, Mayo MA, Maniloff J, Dseelberger U, Ball LA (eds) Virus taxonomy. VIII Report of the ICTV. Elsevier/Academic Press, London, pp 466–483

22.

Mertens PPC, Pedley S, Cowley J, Burrough JN, Cortey AH, Jeggo MH, Jenning DM, Gorman BM (1989) Analysis of the role of bluetongue virus outer capsid proteins VP2 and VP5 in determination of virus serotype. Virology 170:561–565CrossRefPubMed

23.

Mertens PPC, Sangar DV (1985) Analysis of the terminal sequences of the genome segments of four orbiviruses. Virology 140:55–67CrossRefPubMed

24.

Mondal B, Sen A, Chand K, Biswas SK, De A, Rajak KK, Chakravarti S (2009) Evidence of mixed infection of peste des petits ruminants virus and bluetongue virus in a flock of goats as confirmed by detection of antigen, antibody and nucleic acid of both the viruses. Trop Anim Health Prod 41:1661–1667

25.

Odorico M, Pellequer JL (2003) BEPITOPE: predicting the location of continuous epitope and patterns in proteins. J Mol Recognit 16:20–22CrossRefPubMed

26.

Paul E, Gibbs J, Greiner EC (1994) The epidemiology of bluetongue. Comp Immunol Microbiol Infect Dis 17:207–220CrossRef

27.

Pierce CM, Rossitto PV, MacLachla NJ (1995) Homotypic and heterotypic neutralization determinants of bluetongue virus serotype 17. Virology 209:63–267CrossRef

28.

Prasad G, Garg AK, Minakshi KakkerNK, Srivastava RN (1994) Isolation of bluetongue virus from sheep in Rajasthan state. Rev Sci Tech Off Int Epic 13:935–938

29.

Prichard IL, Daniels PW, Melville LF, Kirkland PD, Johnson SJ, Lunt R, Eaton BT (2004) Genetic diversity of bluetongue viruses in Australia. Vet Ital 40:438–444

30.

Saitou N, Nei M (1987) The neighbor joining method: a new method for reconstructing phylogenetic trees. Mol Biol 4:406–425

31.

Schwartz-Cornil I, Mertens PPC, Contreras V, Hemati B, Pascale F, Breard E, Mellor PS, MacLachlan NJ, Zientara S (2008) Bluetongue virus: virology, pathogenesis and immunity. Vet Res 39:46. doi:10.1051/vetres:2008023 CrossRefPubMed

32.

Singh KP, Maan S, Samuel AR, Rao S, Meyer AM, Mertens PPC (2004) Phylogenetic analyses of bluetongue virus genome segment 6 (encoding VP 5) from different serotypes. Vet Ital 40:479–483

33.

Squire KRE, Chuang RY, Osburn BI, Knudson DL, Doi RH (1983) Rapid methods for comparing the double-stranded RNA genome profiles of bluetongue virus. Vet Microbiol 8:543–553CrossRefPubMed

34.

Sreenivasulu D, Subba Rao MV, Reddy YN, Gard GP (2004) Overview of bluetongue disease, viruses, vectors, surveillance and unique features: the Indian sub-continent and adjacent regions. Vet Ital 40:73–77

35.

Sreenivasulu D, Rao MV, Gard GP (1999) Isolation of bluetongue virus serotype 2 from native sheep in India. Vet Rec 144:452–453PubMed

36.

Tamura K, Dudley J, Nei M, Kumar S (2007) MEGA4: Molecular Evolutionary Genetics Analysis (MEGA) software version 4.0. Mol Biol Evol 24:1596–1599CrossRefPubMed

37.

Thompson JD, Higgins DG, Gibson TJ (1994) CLUSTAL W: Improving the sensitivity of progressive multiple sequence alignment through sequence weighting, positions-specific gap penalties and weight matrix choice. Nucleic Acids Res 22:4673–4680CrossRefPubMed

38.

Toussaint JF, Sailleau C, Mast J, Houdart P, Czaplicki G, Demeestere L, VandenBussche F, van Dessel W, Goris N, Breard E, Bounaadja L, Etienne T, Zientara S, De Clercq K (2007) Bluetongue in Belgium, 2006. Emerg Infect Dis 13:614–616CrossRefPubMed

39.

Walton TE (2004) The history of bluetongue and a current global overview. Vet Ital 40:31–38

40.

Wilson WC, Bernard KA, Israel BA, Mecham JO (2008) Bluetongue virus serotype 17 sequence variation associated with neutralization. DNA Seq 19:237–240CrossRefPubMed

41.

Zientara S, Breard E, Sailleau C (2006) Bluetongue: characterization of virus types by reverse transcription-polymerase chain reaction. Dev Biol (Basel) 126:187–196

Title: Segment-2 sequence analysis and cross-neutralization studies on some Indian bluetongue viruses suggest isolates are VP2-variants of serotype 23
Authors: Prabhakar A. Tembhurne
Bimalendu Mondal
Kunj B. Pathak
Sanchay K. Biswas
Aniket Sanyal
Mahendra P. Yadav
Santanu K. Bandyopadhyay
Raj K. Singh
Publication date: 01-01-2010
Publisher: Springer Vienna
Published in: Archives of Virology / Issue 1/2010
Print ISSN: 0304-8608
Electronic ISSN: 1432-8798
DOI: https://doi.org/10.1007/s00705-009-0553-z

Live Webinar | 27-06-2024 | 18:00 (CEST)

Keynote webinar | Spotlight on medication adherence

Reserve your place

Live: Thursday 27th June 2024, 18:00-19:30 (CEST)

WHO estimates that half of all patients worldwide are non-adherent to their prescribed medication. The consequences of poor adherence can be catastrophic, on both the individual and population level.

Join our expert panel to discover why you need to understand the drivers of non-adherence in your patients, and how you can optimize medication adherence in your clinics to drastically improve patient outcomes.

Prof. Kevin Dolgin

Prof. Florian Limbourg

Prof. Anoop Chauhan

Developed by: Springer Medicine

Obesity Clinical Trial Summary

At a glance: The STEP trials

A round-up of the STEP phase 3 clinical trials evaluating semaglutide for weight loss in people with overweight or obesity.

Developed by: Springer Medicine

Keynote webinar | Spotlight on medication adherence

Springer Medicine

Abstract

Please log in to get access to this content

Other articles of this Issue 1/2010

Transition of genotypes associated with norovirus gastroenteritis outbreaks in a limited area of Japan, Hiroshima Prefecture, during eight epidemic seasons

A novel human adenovirus hexon protein of species D found in an AIDS patient

In memoriam: Prof. Thomas Barrett

Gene segment reassortment between Eurasian and American clades of avian influenza virus in Italy

Ratification vote on taxonomic proposals to the International Committee on Taxonomy of Viruses (2009)

Subtype identification of the novel A H1N1 and other human influenza A viruses using an oligonucleotide microarray

Keynote webinar | Spotlight on medication adherence

Live: Thursday 27th June 2024, 18:00-19:30 (CEST)

At a glance: The STEP trials